Aratana Therapeutics Inc (NASDAQ:PETX)

4.40
Delayed Data
As of 4:00pm ET
 -0.02 / -0.45%
Today’s Change
3.67
Today|||52-Week Range
7.16
-28.22%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Aratana Therapeutics Inc have a median target of 8.00, with a high estimate of 10.00 and a low estimate of 5.00. The median estimate represents a +81.82% increase from the last price of 4.40.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Aratana Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.14
Sales
$6.2M
Reporting Date
Mar 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -171.61%
 
 
 
 
 
 
Growthannually 76.72%
 
 
 
 
 
 

Sales

Growthquarterly -71.21%
 
 
 
 
 
 
Growthannually 43.55%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.